The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression

Molecular Oncology - Tập 1 Số 1 - Trang 84-96 - 2007
Paraic A. Kenny1,2, Genee Y. Lee1,2, Connie A. Myers1,3, Richard M. Neve1, Jeremy R. Semeiks1, Paul T. Spellman1, Katrin Lorenz1,4, Eva H. Lee1, Mary Helen Barcellos‐Hoff1, Ole W. Petersen5, Joe W. Gray1, Mina J. Bissell1
1Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, One Cyclotron Road, MS 977-225A, Berkeley, CA 94720, USA
2These authors contributed equally to this report.
3Present address: Division of Neuropathology, Washington University School of Medicine, St. Louis, MO 63110, USA.
4Present address: Department of Molecular Medicine, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
5Structural Cell Biology Unit, Institute of Medical Anatomy, The Panum Institute, University of Copenhagen, DK-2200 Copenhagen N, Denmark

Tóm tắt

Abstract

3D cell cultures are rapidly becoming the method of choice for the physiologically relevant modeling of many aspects of non‐malignant and malignant cell behavior ex vivo. Nevertheless, only a limited number of distinct cell types have been evaluated in this assay to date. Here we report the first large scale comparison of the transcriptional profiles and 3D cell culture phenotypes of a substantial panel of human breast cancer cell lines. Each cell line adopts a colony morphology of one of four main classes in 3D culture. These morphologies reflect, at least in part, the underlying gene expression profile and protein expression patterns of the cell lines, and distinct morphologies were also associated with tumor cell invasiveness and with cell lines originating from metastases. We further demonstrate that consistent differences in genes encoding signal transduction proteins emerge when even tumor cells are cultured in 3D microenvironments.

Từ khóa


Tài liệu tham khảo

Albini A., 1987, A rapid in vitro assay for quantitating the invasive potential of tumor cells, Cancer Research, 47, 3239

10.1038/75556

10.1242/dev.105.2.223

10.1016/j.bbamem.2004.03.012

10.1038/nature04296

10.1083/jcb.59.3.722

10.1083/jcb.50.1.222

10.1016/S0074-7696(08)61130-4

10.1016/0022-5193(82)90388-5

10.1101/sqb.2005.70.013

10.1038/35094059

10.1016/j.ceb.2003.10.016

Bissell M.J., 1999, Tissue structure, nuclear organization, and gene expression in normal and malignant breast, Cancer Research, 59, 1757

Briand P., 1996, Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal, Cancer Research, 56, 2039

10.1007/BF02623578

10.1016/j.ccr.2006.10.009

10.1016/S0092-8674(02)01001-2

10.1083/jcb.200304159

10.1007/BF02616178

10.1016/0006-291X(85)90131-7

10.1158/0008-5472.CAN-06-0515

10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L

10.1158/0008-5472.CAN-05-1196

Hiraguri S., 1998, Mechanisms of inactivation of E-cadherin in breast cancer cell lines, Cancer Research, 58, 1972

10.1083/jcb.200505087

10.1093/nar/gng015

10.1158/0008-5472.CAN-05-2612

10.1073/pnas.89.12.5321

10.1172/JCI29518

10.1016/j.semcancer.2005.05.004

10.1002/j.1460-2075.1987.tb04797.x

10.1023/B:BREA.0000014042.54925.cc

10.1038/nmeth1015

10.1073/pnas.95.25.14711

10.1073/pnas.84.1.136

10.1083/jcb.200306090

10.1016/S0002-9440(10)62338-3

10.1006/excr.1994.1355

10.1038/ncb0901-785

10.1016/j.ccr.2006.10.008

10.1074/jbc.272.40.24735

10.1073/pnas.0605579103

10.1158/0008-5472.CAN-05-3071

10.1073/pnas.96.16.9212

10.1038/35021093

10.1073/pnas.89.19.9064

10.1038/nm1491

10.1038/ncb1026

10.1073/pnas.91.26.12378

10.1016/0955-0674(95)80117-0

10.1242/jcs.00503

10.1091/mbc.3.6.699

10.1083/jcb.115.5.1383

10.1083/jcb.110.4.1405

10.1083/jcb.129.3.591

van de Wetering M., 2001, Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling, Cancer Research, 61, 278

10.1093/jnci/94.19.1494

10.1073/pnas.95.25.14821

10.1016/S1535-6108(02)00125-3

10.1083/jcb.137.1.231

10.1083/jcb.200309102

10.1074/jbc.M610316200

10.1158/0008-5472.CAN-05-4081